In contested areas like gender medicine and antidepressants, personal narratives are used as a rhetorical shield to shut down scrutiny and sustain treatments with weak evidence. This dynamic can misclassify harms (e.g., antidepressant withdrawal as 'relapse') and block better guidelines (e.g., ultra‑slow tapers).
— If anecdotes can trump data in medicine, governance must reassert evidence‑first standards to prevent policy and clinical practice from being captured by emotive narratives.
Carrie Clark
2025.08.26
100% relevant
The author cites her diagnosed antidepressant discontinuation syndrome, a 2019 finding that only 2% recalled withdrawal warnings, and parallels to 'gender‑affirming' care defended via 'lived experience.'
← Back to All Ideas